Table 2. Resource Utilization for Bronchiolitis Across 42 PHIS Hospitals.
| Unadjusted Distribution Across Hospitals (% of patients receiving process across all hospitals) |
Adjusted Distribution Across Hospitals* (% of patients receiving process across all hospitals) |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Min | 25th percentile | Median | 75th percentile | Max | Min | 25th percentile | Median | 75th percentile | Max | |
| Albuterol | 3.4 | 38.9 | 56.3 | 69.7 | 84.2 | 3.5 | 38.2 | 52.4 | 67.2 | 81.0 |
| Racemic Epinephrine | 0.3 | 7.1 | 15.2 | 27.5 | 60.9 | 0.6 | 8.8 | 20.1 | 36.0 | 78.8 |
| Corticosteroids | 4.3 | 6.8 | 10.9 | 14.3 | 44.1 | 4.1 | 7.4 | 10.9 | 15.4 | 46.6 |
| Chest radiograph | 22.6 | 43.9 | 57.4 | 64.9 | 81.0 | 24.1 | 42.4 | 54.9 | 64.1 | 76.7 |
| Antibiotics | 25.4 | 32.8 | 39.0 | 41.6 | 51.5 | 27.1 | 31.4 | 38.4 | 42.8 | 50.1 |
*
Adjusted for patient age, race, year and season of presentation, insurance status and APR-DRG severity score, with hospital-specific random intercepts, representing the degree to which a hospital’s resource use departed from what would be expected on average for a hospital with similar case mix.